Monday, November 30, 2020
Home Authors Posts by Editor / Curator

Editor / Curator

343 POSTS 0 COMMENTS
Video

Kevin Harrington Presentation. (Video)

Editor / Curator -
All News

Holy Cholula! Acquired for $800 Million or Near 10 Times Sales!

Editor / Curator -
Biotech Stock Review
All News

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in...

Editor / Curator -
Roland Rick Perry
Stand Down.

Jeremy Grantham: The Market Bubble Will Burst in Weeks or Months

Editor / Curator -
Mark Washo, Aphex Biocleanse
CoronaVirus

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior...

Editor / Curator -
OMNIQ
Cybersecurity

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

Editor / Curator -
OMQS
Cybersecurity

Adding OmniQ (OMQS) $5.00 to the Watch List.

Editor / Curator -
Hapbee
Telehealth

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Editor / Curator -
All News

Adding Galaxy Digital (GLXY) $5.19 to Watch List.

Editor / Curator -
Dyadic, Biotech Stock Review
2020 Watch List

Dyadic (DYAI) Price Target $12.

Editor / Curator -
123...35Page 1 of 35

Latest article

Kevin Harrington Presentation. (Video)

Video Editor / Curator -
The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...

Holy Cholula! Acquired for $800 Million or Near 10 Times Sales!

All News Editor / Curator -
McCormick to buy hot-sauce maker Cholula for $800 million (CNBC). McCormick said it would buy hot-sauce maker Cholula’s parent...
Biotech Stock Review

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.

All News Editor / Curator -
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.